MicroRNA and Gene Signature of Severe Cutaneous Drug Hypersensitivity Reactions Reveal the Role of miR-483- 5p/miR-28-5p in Inflammation by Targeting Granulysin Gene

Tropical Journal of Pharmaceutical Research - Nigeria
doi 10.4314/tjpr.v16i4.5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

African Journals Online (AJOL)

Related search

MiR-483-5p and miR-139-5p Promote Aggressiveness by Targeting N-Myc Downstream-Regulated Gene Family Members in Adrenocortical Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

MiR-20a-5p Represses the Multi-Drug Resistance of Osteosarcoma by Targeting the SDC2 Gene

Cancer Cell International
Cancer ResearchOncologyGenetics
2017English

miR–483-5p Promotes Prostate Cancer Cell Proliferation and Invasion by Targeting RBM5

International braz j urol : official journal of the Brazilian Society of Urology
MedicineUrology
2017English

miR-483-5p Promotes Invasion and Metastasis of Lung Adenocarcinoma by Targeting RhoGDI1 and ALCAM

Cancer Research
Cancer ResearchOncology
2014English

Figure 6: Quantitative PCR Analysis of miR-26a-5p, miR-181a-5p, miR-34a-5p, miR-93-5p, Pten, Creb, BCL-2, and Sirt1 Expression in miR-26a-5p (A), miR-181a-5p (B), miR-34a-5p (C), miR-93-5p (D) Mimic Transfected HUVECs.

English

Paeonol Attenuates Inflammation by Targeting HMGB1 Through Upregulating miR-339-5p

Scientific Reports
Multidisciplinary
2019English

miR-483-5p Plays a Protective Role in Chronic Obstructive Pulmonary Disease

International Journal of Molecular Medicine
MedicineGenetics
2017English

The Clinical Significance of Downregulation of Mir-124-3p, Mir-146a-5p, Mir-155-5p and Mir-335-5p in Gastric Cancer Tumorigenesis

International Journal of Oncology
Cancer ResearchOncology
2014English

microRNA-342-5p and miR-608 Inhibit Colon Cancer Tumorigenesis by Targeting NAA10

Oncotarget
Oncology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy